ScholarIQanswers from OpenAlex & ORCID
Neal D. Shore
ResearcherPublications, citations & collaboration network
Neal D. Shore is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Neal D. Shore have?
ScholarIQindexed works
Neal D. Shore has 1,308 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Neal D. Shore have?
ScholarIQcitation count
Neal D. Shore has 47,064 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Neal D. Shore?
ScholarIQh-index
Neal D. Shore has an h-index of 86 in OpenAlex.
What is the i10-index of Neal D. Shore?
ScholarIQi10-index
Neal D. Shore has an i10-index of 386 in OpenAlex.
What is the ORCID of Neal D. Shore?
ScholarIQorcid
The ORCID for Neal D. Shore is on the source record.
What is the OpenAlex record for Neal D. Shore?
ScholarIQopenalex
The OpenAlex for Neal D. Shore is on the source record.
What are the most-cited papers on Neal D. Shore?
ScholarIQmost cited works
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono
Olaparib for Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Niven Mehra, Carsten Goessl, Jinyu Kang, Joseph E. Burgents, Wenting Wu, Alexander Kohlmann, Carrie A. Adelman, Maha Hussain
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi, Michael A. Carducci, Matthew R. Smith, Ronaldo Damião, Janet E. Brown, Lawrence I. Karsh, Piotr Milecki, Neal D. Shore, Michael Rader, Huei Wang, Qi Jiang, Sylvia Tadros, Roger Dansey, Carsten Goessl
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
Maha Hussain, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Guilhem Roubaud, Mustafa Özgüroğlu, Jinyu Kang, Joseph E. Burgents, Christopher Gresty, Claire Corcoran, Carrie A. Adelman, Johann S. de Bono
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Alberto Bossi, Robert G. Bristow, Brett S. Carver, Daniel Castellano, Byung Ha Chung, Noel W. Clarke, Gedske Daugaard, Ian D. Davis, Johann S. de Bono, Rodolfo Borges dos Reis, Charles G. Drake, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Celestia S. Higano, Nicolas James, Philip W. Kantoff, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin